Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2000
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055149A1 Dimeric compounds and as inhibitors of neuraminidase
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055143A1 Oxazolone derivatives and their use as alpha-1 adrenoreceptor modulators
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000054806A1 Insulin-like growth factor binding protein-4 protease
09/21/2000WO2000054805A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
09/21/2000WO2000054795A1 Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject
09/21/2000WO2000054792A1 Drugs, foods, drinks and feeds containing cocoa component
09/21/2000WO2000054786A1 Methods and compositions for tolerizing hosts for long term survival of tissue transplants
09/21/2000WO2000054785A2 Stabilized bicyclo[3.3.1]nonenes and methods of use
09/21/2000WO2000054782A1 Treatment of accidental extravasation of anthracyclines
09/21/2000WO2000054773A1 Dopamine agonists in combination with nitric oxide donors, compositions and methods of use
09/21/2000WO2000054772A1 Amyotropic lateral sclerosis treatment with a combination of riluzole and an ampa receptor antagonist
09/21/2000WO2000054766A1 Agents and methods for promoting production gains in animals
09/21/2000WO2000054764A2 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000054760A2 Bicyclo (3.3.1) nonenes useful for the treatment of diabetes and hypertriglyceridemia
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000029846A9 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY
09/21/2000WO2000027207A8 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
09/21/2000WO2000025819A9 Enhanced radiation therapy
09/21/2000WO2000021560A9 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000WO2000010551A3 Methods of using and compositions comprising dopamine reuptake inhibitors
09/21/2000WO1999064378A3 Directed combinatorial compound library and high throughput assays for screening same
09/21/2000DE19910682A1 Fibrate based preparation for treating hyperlipoproteinemia additionally contains vitamin or related compound, e.g. cobalamin or folic acid, to prevent the side effect of hyperhomocysteinemia
09/21/2000CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2367444A1 Agents and methods for promoting production gains in animals
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/21/2000CA2367256A1 Surface localized colligin/hsp47 in carcinoma cells
09/21/2000CA2366838A1 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2363496A1 Differential expression of organellar gene products
09/21/2000CA2363022A1 49 human secreted proteins
09/20/2000EP1036564A1 Thyromimetic antiobesity agents
09/20/2000EP1036510A2 Vitamin formulation for cardiovascular health
09/20/2000EP1036195A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof
09/20/2000EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51
09/20/2000EP1036188A1 ribG
09/20/2000EP1036178A1 Identification of lysolipid receptors involved in inflammatory response
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036086A1 Caspase-14 polypeptides
09/20/2000EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
09/20/2000EP1035856A1 Isolated dna encoding human h3 histamine receptor
09/20/2000EP1035853A1 Use of f prostanoid receptor agonists for treating a bone disorder
09/20/2000EP1035851A2 Method for combating obesity
09/20/2000EP1035843A2 I h?-MODULATORS
09/20/2000EP1035835A1 Long acting injectable formulations containing hydrogenated castor oil
09/20/2000EP1035833A1 Compositions for nasal administration
09/20/2000EP1011705A4 Conjugates targeted to the interleukin-2 receptor
09/20/2000CN1267307A Interleukin-18 binding proteins, their preparation and use
09/20/2000CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b
09/20/2000CN1267219A Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
09/19/2000US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121317 Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing
09/19/2000US6121295 Treating diabetic complications by administering an insulin sensitivity enhancer such as pioglitazone in combination with a statin compound such as pravastatin
09/19/2000US6121294 Reducing the amount of therapeutic agents administered to a diabetic patient by administering an insulin sensitivity enhancer in combination with an alpha-glucosidase inhibitor as said therapeutic agents; side effect reduction
09/19/2000US6121292 Methods for reversing multidrug resistance
09/19/2000US6121290 Use of GABA uptake inhibitors as anti-tussive agents
09/19/2000US6121263 Administering synergistic amount of a 1,2,4-benzotriazine-n-oxide derivative prior to administering taxol
09/19/2000US6121261 Method for treating attention deficit disorder
09/19/2000US6121259 Olanzapine-N-oxide compositions and methods
09/19/2000US6121254 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith
09/19/2000US6121249 Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
09/19/2000US6121245 Method of treating cancer using alkylglycerols in conjunction with chemotherapy
09/19/2000US6121243 Prophylaxis of skin against ageing, against inflammation and for protection from photoreaction and oxidative influences
09/19/2000US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury
09/19/2000US6121230 Administering polypeptide acting as vascular endothelial growth factor antagonist to treat and/or prevent endometriosis
09/19/2000US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents
09/19/2000US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners
09/19/2000US6120803 Having segment of dosage form that is of sufficient rigidity to withstand contractions of stomach and delay expulsion of dosage form from stomach until substantially all of active agent has been dispensed
09/19/2000US6120799 For treatment and diagnosisdiseases and abnormalities such as cancer, wound healing, and chronic inflammatory diseases
09/19/2000US6120777 High fluorescence specific immune enhancing factor and methods of use for same
09/19/2000US6119687 Partial liquid breathing of fluorocarbons
09/19/2000CA2200851C Inhibition of hair growth
09/14/2000WO2000054049A2 Determination of the chemosensitivity via the caspase activity
09/14/2000WO2000053800A1 METHOD TO SEARCH FOR MALE ANTIFERTILITY DRUGS BASED ON PHGPx ACTIVITY DETERMINATION
09/14/2000WO2000053776A2 Human kallikrein-like genes
09/14/2000WO2000053750A1 Compositions and methods for the treatment of tumors
09/14/2000WO2000053748A2 Casb618 polynucleotides and polypeptides and their use
09/14/2000WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053738A2 Methods and compositions for regulating memory consolidation
09/14/2000WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000WO2000053631A1 Mammalian cytokines; related reagents and methods
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053623A1 Bifunctional molecules for delivery of therapeutics
09/14/2000WO2000053606A1 Pyridoxal analogues for vitamin b-6 disorders